Researchers at Northwestern Medicine found that 65% of their lung cancer patients weren't eligible for screening. They were ...

Biomarker testing for 11 oncogenes at diagnosis enables personalized lung cancer treatment, moving away from a ...

The process of TIL therapy is complex and requires the coordination of multiple specialties at authorized treatment centers, ...

With a five-year survival rate of less than 5%, glioblastoma is one of the most aggressive types of brain cancer. Until now, all available treatments, including immunotherapy—which involves ...

Researchers identified a major weakness in lung cancer by blocking FSP1, a protein that protects tumors from ferroptosis. In ...

The Food and Drug Administration (FDA) has granted traditional approval to Imdelltra ® (tarlatamab-dlle) for the treatment of adults with extensive stage small cell lung cancer (ES-SCLC) with disease ...

The US Food and Drug Administration has approved sevabertinib, an oral targeted therapy for adult patients with ...

Drug resistance has long turned some of the most advanced lung cancer therapies into temporary victories, with tumors ...

Researchers uncovered a powerful weakness in lung cancer by shutting down a protein that helps tumors survive stress. When this protein, FSP1, was blocked, lung tumors in mice shrank dramatically, ...

MiNK-215, an IL-15 armoured FAP-targeting CAR-iNKT, targets and clears tumor-protective FAP+ fibroblasts to allow immune cells to infiltrate and ...

After her shocking lung cancer diagnosis, the late Susan Wojcicki dedicated herself to fighting the disease and looking for ...

FDA fast-tracks Bayer's Hyrnuo, unlocking a potential $800 million market and giving the stock another shot of life ...